- Home
- PGEN vs AWP Comparison
PGEN vs AWP Comparison
Compare PGEN & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- AWP
- Stock Information
- Founded
- PGEN 1998
- AWP 2007
- Country
- PGEN United States
- AWP United States
- Employees
- PGEN N/A
- AWP N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- AWP Finance
- Exchange
- PGEN Nasdaq
- AWP Nasdaq
- Market Cap
- PGEN 404.4M
- AWP 342.3M
- IPO Year
- PGEN N/A
- AWP N/A
- Fundamental
- Price
- PGEN $1.32
- AWP $3.95
- Analyst Decision
- PGEN Strong Buy
- AWP
- Analyst Count
- PGEN 4
- AWP 0
- Target Price
- PGEN $7.33
- AWP N/A
- AVG Volume (30 Days)
- PGEN 1.8M
- AWP 331.5K
- Earning Date
- PGEN 05-14-2025
- AWP 01-01-0001
- Dividend Yield
- PGEN N/A
- AWP 12.48%
- EPS Growth
- PGEN N/A
- AWP N/A
- EPS
- PGEN N/A
- AWP N/A
- Revenue
- PGEN $4,201,000.00
- AWP N/A
- Revenue This Year
- PGEN $189.12
- AWP N/A
- Revenue Next Year
- PGEN $1,093.07
- AWP N/A
- P/E Ratio
- PGEN N/A
- AWP N/A
- Revenue Growth
- PGEN N/A
- AWP N/A
- 52 Week Low
- PGEN $0.65
- AWP $3.06
- 52 Week High
- PGEN $2.17
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- PGEN 44.03
- AWP 55.58
- Support Level
- PGEN $1.35
- AWP $3.84
- Resistance Level
- PGEN $1.53
- AWP $3.91
- Average True Range (ATR)
- PGEN 0.12
- AWP 0.07
- MACD
- PGEN 0.00
- AWP -0.00
- Stochastic Oscillator
- PGEN 22.22
- AWP 73.68
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.